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Abstract: Beta-toxin (CPB) is the essential virulence factor of C. perfringens type C causing 
necrotizing enteritis (NE) in different hosts. Using a pig infection model, we showed that 
CPB targets small intestinal endothelial cells. Its effect on the porcine intestinal epithelium, 
however, could not be adequately investigated by this approach. Using porcine neonatal 
jejunal explants and cryosections, we performed in situ binding studies with CPB.  
We confirmed binding of CPB to endothelial but could not detect binding to epithelial cells. 
In contrast, the intact epithelial layer inhibited CPB penetration into deeper intestinal layers. 
CPB failed to induce cytopathic effects in cultured polarized porcine intestinal epithelial cells 
(IPEC-J2) and primary jejunal epithelial cells. C. perfringens type C culture supernatants were 
toxic for cell cultures. This, however, was not inhibited by CPB neutralization. Our results 
show that, in the porcine small intestine, CPB primarily targets endothelial cells and does 
not bind to epithelial cells. An intact intestinal epithelial layer prevents CPB diffusion into 
underlying tissue and CPB alone does not cause direct damage to intestinal epithelial cells. 
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Additional factors might be involved in the early epithelial damage which is needed for CPB 
diffusion towards its endothelial targets in the small intestine.  
Keywords: Clostridium perfringens type C; beta-toxin; endothelium; mucosa; epithelium; 
pathogenesis; porcine 
 
1. Introduction 
The anaerobic, Gram-positive, spore-forming bacterium C. perfringens causes different diseases in 
humans and animals, such as septicemia, myonecrosis, enterotoxemia, food poisoning and enteritis [1]. 
Classification into five types is based on the production of four major toxins: Alpha- (CPA), beta- (CPB), 
epsilon (ETX)- and iota-toxin (ITX) [2]. C. perfringens type C produces CPA and CPB; however, 
additional toxins, such as beta-2 toxin, enterotoxin, perfringolysin and TpeL can be secreted [3,4].  
C. perfringens type C causes necrotizing enteritis (NE) in newborn animals and in humans [1].  
Piglets are most commonly affected and, as in all affected hosts, the hallmark lesion of NE is a severe, 
segmental, necro-hemorrhagic jejunitis [5]. The exact role of different toxins in the pathogenesis of the 
disease is not known yet. Experimental studies using genetic approaches and animal models of disease 
clearly demonstrated that CPB is the essential virulence factor of type C strains [6]. 
CPB is a soluble 35 kDa monomer protein that is thermo-labile and highly sensitive to degradation 
by trypsin [4]. It is a member of the beta-barrel pore-forming toxin family and forms oligomeric  
pores in several susceptible immune cell lines [7,8]. Other studies showed that CPB is required for  
C. perfringens-induced necrotic enteritis in rabbit ileal loops and that purified CPB can produce similar 
lesions [6]. In this model, lesions were reminiscent of early epithelial damage and thus CPB might also 
directly act on intestinal epithelial cells. So far, it is however unknown whether epithelial necrosis is 
caused by a direct effect of the pore-forming toxin on intestinal epithelial cells or indirectly [9,10].  
Our recent work showed that endothelial cells are highly susceptible to CPB [11,12] and that pore-formation 
in endothelial cells rapidly leads to necrotic cell death [13]. In spontaneous disease CPB can be demonstrated 
in endothelial cells [14,15] and this also correlated to early vascular lesions in an experimental infection 
model in pigs [16]. Based on these results, we hypothesized that endothelial cells in the small intestine 
are the primary target for CPB. This however would require that CPB can pass the intestinal epithelial 
barrier to penetrate into deeper mucosal tissue. A direct toxic effect of CPB on porcine small intestinal 
epithelial cells is possible and this would facilitate toxicity on endothelial cells. Our hypothesis was 
however based on analyses of spontaneous end stage lesions [14] and early lesions in experimentally 
infected piglets [16]. Although we could not demonstrate CPB binding to epithelial cells in these studies, 
they were not suitable to investigate early epithelial toxicity as they represent stages where tissue 
necrosis has already begun. Additionally, the piglet intestinal loop model would require a relatively high 
number of lethal infectious experiments to closely monitor initial interactions of CPB with the small 
intestinal epithelium. The aim of our study was therefore to evaluate binding of CPB to cells in the 
porcine small intestinal mucosa and the toxic effect of CPB on cultured porcine small intestinal epithelial 
cells. To achieve this, we chose two experimental approaches: (I) CPB binding studies using neonatal 
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porcine jejunal cryosections and tissue explants; (II) cellular toxicity studies using a porcine jejunal 
epithelial cell line (IPEC-J2) and primary porcine jejunal epithelial cells. 
2. Results 
2.1. Cellular Binding of CPB in Porcine Jejunal Cryosections 
Immunohistochemical stainings of cryosections incubated with supernatants of C. perfringens type C 
NCTC 3180 and type C JF 3721 localized CPB at the endothelium in all layers of the jejunal wall  
(Figure 1A,B). In contrast, no CPB signal could be demonstrated at the epithelium. 
 
Figure 1. Immunohistochemical localization of CPB (Clostridium perfringens beta-toxin) 
in porcine jejunal cryosections. Cryosections of porcine neonatal jejunum were incubated 
with C. perfringens type C NCTC 3180 supernatant (diluted 1:10 in PBS). CPB was 
subsequently detected by immunohistochemistry on endothelial cells (arrowheads) in the 
lamina propria (A) and submucosa (B), but not on epithelial cells (arrows). (C) Magnification 
of B depicting endothelial CPB signal. Representative pictures from one out of two 
independent experiments, magnification 400×. 
2.2. Cellular Binding of CPB in Porcine Jejunal Explants 
Histological sections of the porcine neonatal jejunal explants revealed no morphological differences 
between explants incubated with C. perfringens type C or type A supernatants or toxin free control 
medium. All explants, regardless of the incubation protocol, remained well preserved for the first 4 h of 
the experiment and afterwards showed early signs of autolysis, such as detachment of epithelial cells. 
The maximum length of the experiments was therefore set at 6 h of incubation. 
Immunohistochemical staining of all explants incubated with C. perfringens type C supernatants 
showed binding of CPB to the endothelium (Figure 2A). No CPB signal at the epithelium was detectable. 
In all explants, a weak endothelial signal in vessels and capillaries located directly at the cut margins of 
the explants was visible from 1 h onwards. These signals were not present in vessels located more than 
50 µm from the cut border and were due to diffusion of CPB into the tissue from the cut edges and 
therefore neglected for our analyses. In unmodified explants, weak endothelial signals in the superficial 
lamina propria of the villi became evident after 2 h of incubation (Figure 2B); a weak signal in the 
submucosa of unmodified explants was detectable after 3 h of incubation (Figure 2C). Mechanical 
damage to the epithelium resulted in the rapid appearance of moderate to strong signals at the 
endothelium in the villi (Figure 2A,B). Binding to the endothelium in the submucosa was moderate in 
these preparations (Figures 2C and S1). Detachment of the tunica serosa and tunica muscularis led to the 
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rapid appearance of a stronger CPB signal at the endothelium, especially within the submucosa compared 
to unmodified explants (Figures 2A,C and S1). Detachment of the tunica serosa and tunica muscularis, 
however, did not lead to an increased signal intensity at endothelial cells in the villi compared to 
unmodified explants up to 3 h of incubation (Figure 2A,B). Signal intensities were only increased 
compared to unmodified explants at 4–6 h of incubation. Pre-incubation of the C. perfringens type C 
supernatants with neutralizing anti-CPB antibodies (mAb-CPB) resulted in complete inhibition of CPB 
signals in all preparations (Figure S2). Multi-way ANOVA, corrected for animal and time, showed 
significant differences in scores between the three preparations in the binding of CPB to villous and 
submucosal endothelium (p-values <0.0001). In the case of villous endothelium, all preparation groups 
showed a significant difference from each other in Tukey-Kramer multiple comparison tests. Explants 
with a damaged epithelium had a significantly higher chance of exhibiting a moderate or strong signal at the 
endothelium in villi compared to unmodified explants (OR: 55.3; 95% CI: 15.3–199.0) and explants with 
a detached mucosa (OR: 4.5; 95% CI: 1.5–13.5) (Figure 2B). For the binding site endothelium-submucosa, 
detached mucosa explants differed significantly from explants with damaged epithelium or unmodified 
explants. The chance of detecting a moderate or high signal at the endothelium in the submucosa in 
explants with a detached mucosa was significantly higher than in unmodified explants (OR: 94.0; 95% 
CI: 24.9–355.3) and explants with a mechanically damaged epithelium (OR: 59.5; 95% CI: 17.5–202.1) 
(Figure 2C). There was no significant difference in signal intensities at submucosal endothelia between 
explants with mechanically damaged epithelium and unmodified explants (OR: 1.6; 95% Cl: 0.49–5.0) 
(Figure 2C). 
 
Figure 2. Cont. 
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Figure 2. Immunohistochemical localization of CPB in the subepithelial lamina propria of 
porcine jejunal explants. (A) Jejunal explants were either unmodified (unmodified), the 
epithelium was mechanically damaged (damaged epithelium), or the tunica serosa and tunica 
muscularis were mechanically detached (detached mucosa). Explants were incubated with 
C. perfringens type C supernatant (JF 3721 diluted 1:10 in RPMI), fixed, and CPB was 
detected by immunohistochemistry. After 2 h of incubation, mild to moderate CPB signals 
were detected at endothelial cells close to the damaged epithelium whereas undamaged 
explants showed no or only very mild signals at 2 h. After 5 h of incubation CPB signals 
were overall stronger in tissue with a mechanically damaged epithelium. Binding of CPB to 
the epithelium was not detectable in any explant. Representative pictures from one out of 
three independent experiments, magnification 400×. (B) Mean CPB signal scores and standard 
deviation at endothelium-villi of eight explants in three independent time course experiments. 
(C) Mean CPB signal scores and standard deviation at endothelium-submucosa (fotographs 
depicted in Figure S1) of eight explants in three independent time course experiments. 
These results showed that CPB has a high affinity to endothelial cells in porcine jejunal explants. 
Despite the lack of epithelial signals in immunohistochemistry, binding of small amounts of CPB to 
epithelial cells, which could be missed using this technique, cannot be excluded. However, intact small 
intestinal epithelium seems to act as a diffusion barrier for CPB and prevent tissue penetration of the 
toxin to reach endothelial cells in the lamina propria and deeper intestinal layers. 
2.3. Trans Epithelial Electrical Resistance Measurements (TEER) 
2.3.1. Apical Exposure of Polarized Porcine Small Intestinal Cells Layers to C. perfringens Type C 
Culture Supernatants and rCPB 
To evaluate the effect of C. perfringens type C culture supernatants and purified recombinant CPB 
(rCPB) on the porcine intestinal epithelium, a porcine jejunal epithelial cell line (IPEC-J2) forming a 
polarized continuous and tight epithelial layer on Transwells® [17] was apically incubated with late log 
phase culture supernatants of two C. perfringens type C strains diluted in cell culture medium.  
Non-inoculated, sterile TGY and supernatants of a C. perfringens type A strain (JF 3693) were used as 
negative controls. Apical incubation with undiluted sterile TGY reduced the TEER below 1 kΩ cm2 but 
did not do so at a 1:2 dilution. Therefore, all culture supernatants were used at a 1:2 dilution in cell 
culture medium to achieve maximum CPB concentrations. Similar to TGY, the C. perfringens type A 
supernatant did not have a significant effect on TEER. As a positive control, we used the pore-forming 
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toxin aerolysin (100 ng/mL) which is known to damage epithelial cells [18]. Apical incubation of  
IPEC-J2 with aerolysin resulted in a significant drop of TEER values below 1 kΩ cm2 within 1 h and a 
subsequent further decline (Figure 3A). The NCTC 3180 supernatant used at a 1:2 dilution (7.5 µg CPB/mL) 
induced a drop of TEER values below 2 kΩ cm2 at 2 h which subsequently further declined (Figure 3A). 
The supernatant of JF 3721 (2.2 µg CPB/mL) induced a drop in TEER below 2 kΩ cm2 starting at 12 h 
(Figure 3A). Pre-incubation of both type C supernatants with neutralizing mAb-CPB did not reduce this 
effect. Additionally, both C. perfringens type C culture supernatants used at a 1:10 dilution, which 
contained CPB at a concentration of 1.5 µg/mL (NCTC 3180) and 440 ng/mL (JF 3721), did not cause 
a drop of TEER below 2 kΩ cm2 over 48 h (Figure S3). 
(A) 
Figure 3. (A) Apical exposure of IPEC-J2 cell layers to rCPB does not affect the TEER. 
IPEC-J2 cells grown on collagen coated Transwells® were incubated with C. perfringens 
supernatants (diluted 1:2 in cell culture medium), TGY (1:2), or rCPB (32 µg/mL) in the 
apical compartment. Aerolysin used as positive control caused a rapid and sustained drop in 
TEER. Apical incubation of type C supernatants caused a drop of TEER values within 2 h 
(NCTC 3180) or 12 h (JF 3721) below 2 kΩ cm2. rCPB did not cause a drop of TEER below 
2 kΩ cm2, similar to type A supernatants and TGY used as controls. Values represent means 
of three independent experiments with a total of eight separate Transwells®. Error bars 
represent two-fold standard deviation. Asterisks indicate values which differ significantly 
from the TGY control group. (B) Endothelial cells (PAEC) co-cultivated in the basolateral 
compartment of Transwells® of IPEC-J2 cells apically exposed to rCPB (32 µg/mL) did not 
exhibit a cytopathic effect. (C) Mechanical damage of the IPEC-J2 layer resulted in 
cytopathic effects in co-cultivated PAEC when the same supernatant as in B was added to 
the apical compartment. Co-cultivation was performed for 48 h. 
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Dunn’s Z multiple comparison test revealed a significant difference between TEER values of 
Transwells® of the TGY control group and Transwells® which had been incubated with aerolysin, 
neutralized or non-neutralized NCTC 3180 supernatants for 1 h–48 h. TEER values of Transwells® 
which had been incubated with neutralized JF 3721 supernatant differed significantly from the TGY 
control group at 12 h–48 h, whereas TEER values of Transwells® incubated with JF 3721 differed 
significantly at 24 h–48 h. No significant differences were present between Transwells® incubated with 
type C supernatants (NCTC 3180, JF 3721) and the corresponding supernatants pre-incubated with 
neutralizing anti-CPB antibodies. No significant differences were detected between TEER values of 
Transwells® that had been incubated with C. perfringens type A and the TGY control group. 
Our results using C. perfringens type C culture supernatants indicated that CPB was not likely to be 
the epithelium damaging factor in our experiments. To further evaluate whether CPB was directly toxic 
to the intestinal epithelium, we incubated polarized IPEC-J2 cells with purified rCPB at a concentration 
of 32 µg/mL. Recombinant CPB was previously shown to be highly toxic to primary endothelial cells at 
concentrations of 13 ng/mL, which was in the same range of toxicity as C. perfringens type C derived 
CPB [11]. Even at these approximately 2000-fold higher concentrations, rCPB did not induce a drop of 
TEER in polarized IPEC-J2 cells (Figure 3A). A lack or the complete loss of cytotoxic activity of rCPB 
was excluded by incubating PAEC monolayers grown in 96-well plates with apical medium/toxin 
preparations at the end of each experiment. After 48 h of apical incubation of IPEC-J2, rCPB preparations 
still induced cell death in PAEC. This effect was inhibited by antibody mediated neutralization of CPB. 
To evaluate whether rCPB was able to pass the polarized IPEC-J2 layer in the Transwells®, PAEC were  
co-cultivated in the basolateral chamber. Using this approach, no cytopathic effect was observed after 48 h 
of apical incubation of the IPEC-J2 with rCPB (Figure 3B). Mechanical destruction of the IPEC-J2 layer 
before apical incubation with rCPB resulted in marked cytotoxicity in co-cultivated PAEC (Figure 3C). 
2.3.2. Basolateral Exposure of Polarized Porcine Small Intestinal Cells Layers to C. perfringens  
Type C Culture Supernatants and rCPB 
Basolateral exposure of IPEC-J2 cell layers to aerolysin as a positive control resulted in a rapid and 
complete loss of the TEER of polarized IPEC-J2 layers (Figure 4). TGY did not have an effect on the 
TEER up to a dilution of 1:5 and the control C. perfringens type A supernatant also did not induce a drop 
in TEER below 2 kΩ cm2 at this concentration. Basolateral incubation of polarized IPEC-J2 cells with the 
supernatant of NCTC 3180 diluted 1:10 in cell culture medium resulted in a rapid decline of TEER.  
After 1 h, TEER values dropped below 2 kΩ cm2 and subsequently declined (Figure 4). Pre-incubation of 
the supernatants with neutralizing mAb-CPB did not reduce this effect. Basolateral incubation with 
supernatant of JF 3721 diluted 1:10 in cell culture medium did not induce a drop of TEER values below 
2 kΩ cm2 (Figure S4), however increasing the concentration to a 1:5 dilution resulted in a significant 
drop at 24 h with a subsequent further decline (Figure 4). Pre-incubation with mAb-CPB had no effect 
on this drop in TEER. Recombinant CPB at a concentration of 32 µg/mL did not induce a significant 
drop in TEER when applied basolaterally. Dunn’s Z multiple comparison tests revealed a significant 
difference between TEER values of the TGY control group and TEER values of IPEC-J2 grown on 
Transwells® which had been incubated with aerolysin and the supernatant of NCTC 3180 (1:10) neutralized 
with mAb-CPB from 1 h–48 h. TEER values of non-neutralized NCTC 3180 differed significantly from  
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2 h to 48 h from the TGY control group. TEER values of Transwells® incubated with supernatant of JF 
3721 neutralized or non-neutralized differed significantly from 24 h to 48 h from the TGY control group. 
Similar to apical exposure no significant differences were present between Transwells® incubated with 
type C supernatants (NCTC 3180, JF 3721) and the corresponding neutralized supernatants. Similar to 
apical exposure experiments, 32 µg/mL CPB in the basolateral chamber of the Transwells® did not 
reduce the TEER below 2 kΩ cm2. 
 
Figure 4. Reduction of TEER upon basolateral exposure of IPEC-J2 cells to C. perfringens 
type C culture supernatants but not rCPB. IPEC-J2 cells were incubated in the basolateral 
compartment of the Transwell® with the same toxins and supernatants (diluted 1:10 and 1:5) 
as in Figure 3. Aerolysin and the C. perfringens type C supernatant NCTC 3180 (1:10) caused 
a rapid and sustained drop in TEER. This effect could not be inhibited by neutralization of 
CPB using mAb-CPB. Supernatants of JF 3721 induced a drop in TEER within 12 h and 
supernatants of JF 3693 within 48 h. rCPB (32 µg/mL), or TGY (1:5) resulted in a small 
drop of TEER values, which however never dropped below 2 kΩ cm2 and subsequently 
increased towards the end of the experiment. Values represent means of three independent 
experiments with a total of eight separate Transwells®. Error bars represent two-fold standard 
deviation. Asterisks indicate values which differ significantly from the TGY control group. 
Culture supernatants were considerably more toxic when IPEC-J2 cell layers where exposed 
basolaterally compared to apical exposure. However, lack of inhibition of the toxic effect by neutralization 
of CPB and the lack of effect of high rCPB concentrations again indicated that CPB was not essential for 
this effect. 
2.4. Exposure of Primary Porcine Small Intestinal Epithelial Cells to C. perfringens Type C Culture 
Supernatants and rCPB 
To exclude that the lack of effect of CPB on polarized IPEC-J2 cell layers was cell line specific, we 
additionally cultured primary porcine neonatal jejunal epithelial cells. Exposure of primary jejunal 
epithelial cell monolayers to NCTC 3180 supernatants caused a cytopathic effect at a dilution of  
1:20–1:40 (Figure 5). JF 3721 supernatants caused a cytopathic effect at a dilution of 1:2–1:20  
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(Figure 5). For both type C supernatants, this cytopathic effect was still detectable after pre-incubation 
with neutralizing antibody mAb-CPB (Figure 5). Recombinant CPB at a concentration of 32 µg/mL 
(Figure 5) or supernatant of C. perfringens type A JF 3693 (data not shown) did not cause a cytopathic 
effect in primary jejunal epithelial cells. 
 
Figure 5. Lack of cytopathic effect of CPB to primary porcine jejunal epithelial cells.  
rCPB added to the cell culture medium did not cause a cytopathic effect on primary porcine 
intestinal epithelial cells. Exposure of these cells to C. perfringens type C NCTC 3180 and 
JF 3721 supernatants caused a cytopathic effect, which was not inhibited by pre-incubation 
with mAb-CPB. Incubation time 48 h. 
3. Discussion 
C. perfringens type C causes lethal necrotizing enteritis in animals and humans. We previously 
showed that endothelial cells are targets for CPB in the porcine small intestine. However, a direct toxic 
effect of CPB on intestinal epithelial cells was also possible. Using porcine small intestinal mucosal 
explants and cryosections incubated with C. perfringens type C culture supernatants, we now confirmed 
that CPB preferentially binds to endothelial cells in the porcine small intestinal mucosa but not to 
epithelial cells. Mechanical damage to the epithelium of intestinal explants led to a more rapid binding 
of CPB to endothelial cells and overall stronger CPB signals at the endothelial lining of vessels. Our 
results suggest that undamaged intestinal epithelium acts as a barrier against tissue penetration of CPB. 
To further evaluate the potential toxic effect of CPB on porcine small intestinal epithelial cells,  
we investigated the effect of C. perfringens type C culture supernatants and purified rCPB on polarized 
IPEC-J2 cells. These cells form continuous and tight polarized epithelial layers when grown on 
permeable filters [17] and have frequently been used as a model to investigate the interaction between 
the porcine intestinal epithelium and bacterial pathogens [19,20]. Apical and basolateral exposure of 
these cells to medium containing 32 g/mL rCPB, a concentration which is approximately 2000-fold 
higher than the reported toxicity to primary porcine endothelial cells [11,12], did not affect the TEER of 
IPEC-J2 cell layers. This indicates that CPB alone was not toxic to the polarized epithelium. 
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Additionally, we could not detect any toxicity on co-cultivated endothelial cells in the basolateral 
compartment when IPEC-J2 cells were exposed apically to rCPB, despite the fact that the toxin in the 
apical chamber was still active on endothelial cells at the end of the experiment. Additionally, rCPB did 
not affect primary porcine intestinal epithelial cells. 
In contrast to purified rCPB, the supernatants of two C. perfringens type C strains, one NCTC 
reference strain and a pathogenic porcine isolate, disrupted the epithelial IPEC-J2 layer when incubated 
at the apical and basolateral side. The supernatants were generated in TGY bacterial culture medium 
under conditions optimized for CPB production and were used at the maximum concentration which 
allowed exclusion of adverse effect by the bacterial culture medium itself. They contained 7.5/1.4 
(apical/basolateral exposure to NCTC 3180) or 2.2/0.88 (apical/basolateral exposure to JF 3721) g/mL 
CPB, concentrations that were 150–500 fold higher than the toxic concentration for endothelial cells [11]. 
The same supernatants, albeit at lower concentrations, were also toxic to primary porcine small intestinal 
epithelial cells. Importantly, the toxic effect of type C supernatants was not reduced when they were  
pre-incubated with neutralizing anti-CPB antibodies. This indicates that CPB was not responsible for the 
cytopathic effects. 
From our results, we conclude that CPB is non-toxic to polarized IPEC-J2 and primary porcine jejunal 
epithelial cells at concentrations which are regularly secreted by C. perfringens type C isolates under 
normal growth conditions during late log phase. 
In addition, our results show that CPB by itself cannot pass the intact IPEC-J2 polarized epithelial 
layer under the culture conditions used in our experiments. Together with our data showing decreased 
tissue penetration in unaltered mucosal explants, this suggests that CPB by itself does not readily pass 
the intact small intestinal epithelial layer. The most likely explanation for these observations is that 
intestinal epithelial cells are inert to CPB and that the toxin cannot pass the epithelium either by the 
paracellular route, which would require damage to tight junctions, or transcellularly. It should be 
mentioned that the IPEC-J2 cell line grown on Transwells® are unlikely to fully match all physiological 
properties of the porcine neonatal jejunal epithelium. For example, the small intestinal epithelium  
of newborn piglets also contains vacuolated fetal-type enterocytes (VFE), which enable the transfer of 
intestinal contents across the epithelium [21]. Therefore, for example trans- or para-cellular transport of 
CPB occurring in vivo at the jejunal epithelial barrier in newborn piglets cannot be excluded by our results. 
Our results further indicate that other secreted factors can induce cytopathic effects in intestinal 
epithelial cell cultures. In contrast to the effects in cell culture systems, lytic effects of culture 
supernatants on mucosal explants were not detected. However, as this approach is limited by the onset 
of post-mortem autolytic effects, it is not well suited to detect such effects. The effect observed in cell 
culture could be due either to a direct toxicity of secreted factors to epithelial cells or the result of damage 
to the underlying collagen layers which were used in both cell culture systems. Given the complex 
pathogenesis of clostridial enteric infections, it is likely that several factors contribute to an initial 
epithelial damage that, in the case of C. perfringens type C infections, enables CPB to penetrate the 
epithelial barrier and act on endothelial cells. Such effects do not necessarily have to be related to direct 
toxicity by a particular toxin or enzyme. Recently several publications suggested synergistic effects of 
secreted C. perfringens toxins in gas gangrene [22] but also enteric infections. Verherstraeten et al. [23] 
reported on synergistic effects of PFO and CPA in bovine C. perfringens type A induced necrohemorrhagic 
enteritis and Ma et al. [24] demonstrated a synergistic effect of enterotoxin (CPE) and CPB from 
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pathogenic human C. perfringens type C isolates in rabbit ileal loops. Our strains did not carry the  
cpe gene; thus, CPE as a contributing factor can be excluded in our experiments. 
In limited evaluations we were not able to correlate the toxic effects to the level of alpha-toxin (CPA), 
perfringolysin (PFO) and collagenase. We did not investigate the contribution of further toxins known 
to be produced by C. perfringens type C strains such as Tpel or beta-2-toxin. Further studies including 
exposure to purified toxins or enzymes and toxin gene knockout mutants of C. perfringens would be 
needed to identify particular virulence factors which are involved in intestinal epithelial damage.  
In addition, genome and plasmid sequencing of C. perfringens type C strains and analyses of culture 
supernatants might reveal additional virulence factors in the future. 
Interestingly, purified CPB alone injected into rabbit ileal loops rapidly causes necro-hemorrhagic 
lesions [25] which raises the question whether CPB alone could act on epithelial cells. However,  
it should be taken into account that ileal loop models in any species represent an unphysiological 
condition in the intestine. Disruption of normal intestinal motility and passage will unequivocally lead 
to changes in the microflora and could have rapid functional effects on the small intestinal mucosal 
barrier, which might not be depicted by morphological studies. In addition, the ligations themselves will 
induce pressure and ischemic damage to the intestinal wall and also epithelium which, at least locally, 
will disrupt the epithelial barrier of the intestine. In this respect, it is noteworthy that control loops in the 
experiments of Ma et al. [24] inoculated with culture medium alone histologically also showed very 
minor lesions. These might be sufficient to allow CPB to pass the intestinal epithelium and target 
susceptible cells in the lamina propria and deeper layers of the mucosa. Another reason for the 
discrepancy between our results and the effects of purified CPB in rabbit intestinal loops and a recently 
developed mouse oral and duodenal inoculation model [26] could be different susceptibilities of cells in 
rabbits, mice and pigs to CPB. CPB is a beta-barrel pore forming toxin [27]. These toxins are secreted 
as monomers and bind to susceptible target cells via specific receptors, where they oligomerize and 
finally form a membrane spanning pore [27]. Cellular receptors of CPB and therefore their distribution 
on different cells and in different species are still unknown. Beta-toxin has been shown to form 
oligomeric pores in several human immune cell lines [7,8] and endothelial cells [28]. In immune cell 
lines and endothelial cells [13] this leads to rapid cell death. Many other cells, such as Hela-,  
Vero-, CHO-, MDCK-, Cos-7-, P-815, PC12 and fibroblasts cells, were reported to be insensitive to 
CPB [7,11,12,29,30]; however, literature comparing cellular susceptibilities to CPB is rare. The most 
likely explanation for this effect is the differential expression of CPB receptors on these cells. Similarly, 
receptors could be differentially expressed between different species and therefore the different models 
used to study the mode of action of CPB might not directly be comparable. 
4. Conclusions 
In conclusion, we confirmed that in the porcine small intestine, CPB preferentially binds to 
endothelial cells and that it does not appear to bind to small intestinal epithelial cells nor does it have a 
direct toxic effect on the porcine small intestinal epithelium. This further supports the hypothesis that 
local damage to the intestinal vasculature mediated by CPB is a key trigger for the development of the 
disease. Additional secreted factors but also intestinal environmental changes occurring during the onset 
of C. perfringens type C enteritis are potentially involved in primary epithelial damage, which is required 
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for the diffusion of CPB through the intestinal epithelial barrier to reach its main target: endothelial cells. 
Together with results from recent studies by other groups, we can hypothesize on several key events in 
the pathogenesis of C. perfringens type C enteritis (Figure 6). Further research will be needed on the 
complex interaction of C. perfringens with the intestinal microenvironment, the mucosa and associated 
immune system, epithelium damaging factors and receptor identification of different toxins in order to 
gradually complete our picture of the complex pathogenesis of clostridial enteric diseases. 
 
Figure 6. Hypothesis on key events of C. perfringens type C induced necrotizing enteritis in pigs 
triggered by CPB: Enteric disease most likely results from a coordinated interplay between different 
events and factors. (1) The disease starts with colonization and rapid proliferation of C. perfringens 
type C. (2) Initial epithelial damage/irritation could be caused by secreted toxins and/or be due to the 
altered luminal environment. This enables CPB to pass the epithelial barrier and diffuse into the 
lamina propria. 3. Due to the high susceptibility of endothelial cells to CPB, even small amounts of 
CPB reaching the endothelium result in local vascular leakage. (3) This increases epithelial damage and 
leakage of blood and tissue components into the intestinal lumen which favors clostridial growth and 
toxin production [31]. (4) Due to the high proliferative capacity of C. perfringens under these local 
environmental conditions, a vicious cycle of CPB induced hemorrhage, accelerated clostridial growth 
and toxin secretion develops. (5) This would explain the rapidly progressing hemorrhage and 
necrosis of the small intestine, the hallmark lesion of C. perfringens type C enteritis. In addition, 
toxins from the intestinal lumen can be absorbed into the systemic circulation and cause 
enterotoxemia. Toxicity of CPB to immune cells [8] could additionally contribute to the disease at 
various stages. Not depicted in our hypothesis model is the mucous layer on the epithelium. 
Currently, we have no knowledge about interactions of C. perfringens type C with this important 
protective layer in the small intestine. 
5. Experimental Section 
5.1. Production of C. perfringens Culture Supernatants, Recombinant CPB and Aerolysin 
C. perfringens strains used were: The porcine C. perfringens type C strain JF 3721 [11] (genotype: 
cpa, cpb, cpb2, pfo, tpel) isolated from an outbreak of NE in 2006, the type C reference strain NCTC 
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3180 (sheep peritonitis isolate; genotype: cpa, cpb, cpb2, pfo, tpel) and the porcine C. perfringens type 
A strain JF 3693 [11] (porcine isolate; genotype cpa, cpb2, pfo) were grown anaerobically on blood agar 
plates. Overnight anaerobic cultures were produced using liquid TGY broth (trypsin glucose yeast 
extract broth, 3% tryptic soy broth (BD 286220), 2% D(+) glucose (Merck Millipore, Darmstadt, 
Germany), 1% yeast extract (BD 212750), 0.1% L-cysteine hydrochloride (Sigma-Aldrich, St. Louis, 
MO, USA) as described previously [11]. Aliquots of these cultures were transferred to 50 mL TGY and 
cultivated until they reached late-log phase. The cultures were then chilled on ice and centrifuged 
(Hettich, Rotanta 460 R, 2602 g, 4 °C, 20 min). Supernatants were sterile filtered using 0.22 µm Millex 
GV filter units (Merck Millipore, Darmstadt, Germany) and stored on ice until use in the experiments 
within the next three hours. The amount of CPA in the supernatant was quantified using an  
Alpha Toxin Elisa Kit (Bio-X Diagnostics, Jemelle, Belgium) with C. perfringens phospholipase C 
(Sigma-Aldrich, St. Louis, MO, USA) as standard. Collagenase activity was quantified using the 
EnzChek® Gelatinase/Collagenase Assay Kit (Molecular Probes®, Lifetechnologies™, Carlsbad, CA, 
USA) according to the manufacturer’s recommendation. Western-blots to quantify CPB in culture 
supernatants were carried out as described [11]. Perfringolysin activity was measured using a dilution 
horse erythrocyte hemolysis assay as described previously [32,33]. Toxin concentrations of the  
C. perfringens strains were: JF 3721: 4.4 µg/mL CPB, 24 µU/mL CPA, 3343.56 U/mL collagenase activity, 
4 PFO activity Log2 (titer); NCTC 3180: 15 µg/mL CPB, 110 µU/mL CPA, 5179.04 U/mL collagenase 
activity, 5.75 PFO activity Log2 (titer); JF 3693: 33 µU/mL CPA, 4041.69 U/mL collagenase activity, 
4.25 PFO activity Log2 (titer). Expression and purification of rCPB was performed as described [11]. 
Cytotoxic activity of rCPB and C. perfringens type C culture supernatants to primary porcine endothelial 
cells (PAEC) was verified before every experiment and was similar to our previous study, where diluted  
C. perfringens type C supernatants containing 15 ng/mL CPB and rCPB concentrations of 13 ng/mL 
were still toxic to PAEC [11]. Proaerolysin was kindly provided by F. G. van der Goot (Global Health 
Institute, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland) and activated as described [34]. 
5.2. Jejunal Explants, Histology, Immunohistochemistry 
All animal procedures were approved by the Bernese Cantonal Veterinary Office and the ethical 
committee of the Faculty of Veterinary Medicine, Ghent University. Four neonatal, colostrum deprived 
piglets were deeply anaesthetized (Stresnil® 0.05 mL/kg, Sanochemia Pharmazeutika AG, Neufeld, 
Austria; Ketanerkon® 0.15 mL/kg, Streuli Pharma AG, Uznach, Switzerland; Morphasol 0.03 mL/kg, 
Dr. E. Gräub AG, Bern, Switzerland) and euthanized by exsanguination. The jejunum was  
immediately harvested and transferred to PBS containing 1× antibiotic/antimycotic (Ab/Am, Gibco®, 
Lifetechnologies™, Carlsbad, CA, USA). Sections of 10 cm were opened and flushed several times. The 
samples were transferred to RPMI 1640 (Gibco®, Lifetechnologies™, Carlsbad, CA, USA; Catalog 
number 21875) containing 1 × Ab/Am and 150 µg/mL trypsin inhibitor (TI, Trypsin inhibitor from 
Glycine max (soybean), Sigma-Aldrich, St. Louis, MO, USA). Intestinal samples were prepared in three 
different ways: Explants remained unmodified (unmodified), the epithelial layer was damaged by 
scraping with a scalpel blade (damaged epithelium), or the tunica serosa and tunica muscularis were 
mechanically detached by pulling with forceps, with only the submucosa and mucosa remaining (detached 
mucosa). The explants were then cut in approximately 1 cm sections and transferred to 6-well-plates. Each 
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well contained 6 mL of C. perfringens culture supernatant diluted 1:10 in RPMI (1 × Ab/Am, 150 µg/mL TI). 
TGY diluted 1:10 in the same medium and medium without additives were used as controls. The explants 
were incubated at a temperature of 37 °C. At different time points (1, 2, 3, 4, 5, 6 h) explants were placed 
in 10% buffered formalin and fixed for 24 h at room temperature (RT). Tissue sections were then 
embedded in paraffin and routinely processed for histology, cut into 5 µm sections and stained with 
hematoxylin and eosin (HE). Immunohistochemical analyses were performed using monoclonal  
anti-CPB antibodies (mAb-CPB 10 A2, Centre for Veterinary Biologics, Ames, IA, USA) as described 
previously [15]. Each experiment using tissue explants was performed independently three times on 
tissue from different piglets. Binding of CPB to endothelial cells within villi or the submucosa and/or 
epithelial cells was determined by light microscopy and graded according to the following grading 
scheme: 0 = no signal, 1 = weak signal, only a small number of vessels (up to 30%) were affected,  
2 = moderate signal, a moderate number of vessels (30%–70% of vessels) were affected 3 = strong signal, 
most vessels (more than 70%) were affected. 
5.3. Binding Studies in Intestinal Cryosections 
Jejunal tissue of a freshly euthanized colostrum deprived neonatal piglet was flushed several times in 
PBS, embedded in Tissue Tek O.C.T Compound. (Sakura Finetec USA, Torrance, CA, USA) and frozen 
in liquid nitrogen. Blocks were stored at −80 °C and cut at a temperature of −20 °C into 4.5 µm sections 
using a cryomicrotome. Tissue sections were mounted on Superfrost® plus glass slides (Thermo 
Scientific, Waltham, MA, USA) and were stored at −20 °C. Tissue sections were incubated for 15 h at 
4 °C with supernatant of C. perfringens strains NCTC 3180, JF 3721, JF 3693 diluted 1:10 in PBS. No 
fixation was performed prior to immunostaining. Sections were washed with PBS and immunohistochemical 
detection of CPB was performed using the same protocol as for paraffin sections [15]. The experiment 
was performed independently twice on tissue sections from two different animals. 
5.4. Antibody Neutralization Experiments  
C. perfringens type C culture supernatants were pre-incubated with neutralizing mAb-CPB for 1 h as 
previously described [11]. 
5.5. Cell Cultures 
Primary porcine aortic endothelial cells (PAEC) were obtained and grown as described [11]. The intestinal 
porcine jejunal cell line (IPEC-J2) [19] was grown in cell culture medium (DMEM/Ham’s F12, Gibco; 
2× Insulin-Transferrin-Selenium (Gibco®, Lifetechnologies™, Carlsbad, CA, USA); 5% fetal calf serum 
(FCS); 1 × Ab/Am; 1 × L-Glutamine (Gibco®, Lifetechnologies™, Carlsbad, CA, USA). For the isolation 
of primary porcine intestinal epithelial cells 20 cm segments of jejunum were obtained from a freshly 
euthanized piglet and transferred to a petri dish containing Hanks’ balanced salt solution (HBSS, Gibco; 
5 × Ab/Am). Segments were rinsed with HBSS 5 × Ab/Am and opened longitudinally. The mucosa was 
mechanically detached from the tunica muscularis and tunica serosa and cut into 3 mm pieces. These 
were washed with HBSS 5 × Ab/Am, transferred to 15 mL HBSS 1 × Ab/Am containing 10 µg/mL 
Collagenase/Dispase (Roche Diagnostics GmbH, Mannheim, Germany) and incubated for 60 min at  
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37 °C under gentle agitation. Finally, the tissue was dissociated by incubation in trypsin EDTA, sieved 
using BD Falcon® cell strainers (70 µm, Fisher Scientific, Lucens, Switzerland, REF 352350) and 
centrifuged (131 g, RT, 15 min). The cell pellets were resuspended in medium (DMEM; 5% FCS;  
1× Insulin-Transferrin-Selenium; 5 ng/mL epidermal growth factor (EGF, Invitrogen™, Lifetechnologies™, 
Carlsbad, CA, USA); 1 × Ab/Am) and seeded at a density of 3 × 104/cm2 onto collagen coated (4 µg collagen 
(bovine collagen 1, Cultrex®, Trevigen, Gaithersburg, Maryland, USA)/cm2) 6-well plates. Medium was 
replaced after 24 h and then every 3 days. Initially isolated cells reached confluency after 7–14 days. 
Epithelial origin of primary cells was confirmed using immunofluorescence for cytokeratin. These primary 
porcine intestinal epithelial cells were then seeded on collagen coated 8-well Nun™ Lab Tek™ (Thermo 
Scientific, Waltham, MA, USA), grown for 5 days until confluency and fixed with acetone for 10 min at 
−20 °C. Cells were incubated 1 h RT with monoclonal anti-cytokeratin 18 antibody (Sigma-Aldrich,  
St. Louis, MO, USA) followed by AlexaFluor goat-anti mouse IgG (Lifetechnologies™, Carlsbad, CA, 
USA). All washing steps were performed with PBS pH 7.5, three times for 5 min. 
5.6. Transepithelial Resistance Measurements 
IPEC-J2 were seeded onto Transwell® (Sigma-Aldrich, St. Louis, MO, USA) membranes (6.5 mm 
Transwell®-COL Collagen-Coated 0.4 pore PTFE Membrane Insert) with a density of 105/Transwell® 
and kept in culture for 8–14 days, until trans epithelial electrical resistance (TEER) reached a minimum 
of 2 kΩ/cm2. These TEER values are indicative of a continuous epithelial layer with tight junction 
formation [35]. TEER was measured using the EVOM2 Voltohmmeter (World Precision Instruments, 
Sarasota, FL, USA). Diluted rCPB, C. perfringens culture supernatants or control medium was added 
either in the apical (containing 200 L fluid) or the basolateral chamber (containing 1 mL fluid) of the 
Transwell®. C. perfringens culture supernatants diluted 1:2 for apical incubation and 1:5 or 1:10 for 
basal incubation in cell culture medium were used. Higher concentrations of supernatants were not used 
because at these concentrations non-inoculated (sterile) TGY started to affect TEER values. Confluent 
monolayers of PAEC grown on fibronectin (1 µg fibronectin (Fibronectin, plasma, purified human, 
Calbiochem)/cm2) coated glass cover slips were placed in the basolateral compartment (24-well cell 
culture plates) of Transwell® for co-cultivation experiments. To test for residual CPB activity in medium 
from the apical chamber at the end of the experiments, twofold dilution steps of the medium in this 
chamber were added to confluent PAEC grown in 96-well plates. Cytopathic effects in PAEC were 
evaluated after 24 h of incubation by light microscopy. 
5.7. Cytotoxicity in Primary Porcine Jejunal Epithelial Cells  
For detection of cytopathic effects in primary intestinal epithelial cells, two-fold dilution steps of 
rCPB and supernatants of C. perfringens strains were added to confluent monolayers grown in collagen 
coated 96-well plates. Cytopathic effects were evaluated after 24 h of incubation by light microscopy. 
5.8. Statistical Analyses 
Statistical analyses were carried out using NCSS 9 Data software (NCSS, LLC, Kaysville, UT, USA). 
Multi-way ANOVA was performed to assess differences in signal intensity between the three different 
preparation groups (unmodified, damaged epithelium, detached mucosa) of the explant study. Values 
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were corrected for time and animal, at different locations of the endothelium (i.e., in villi and submucosa) 
and epithelium separately. Identification of different groups was done via Tukey-Kramer multiple 
comparison tests. Since not all model assumptions were met (e.g., the dependent variable was not truly 
continuous), a multivariable logistic regression analysis was performed to confirm results of the previous 
analyses. Therefore, the dependent variable was recoded into two categories (no to weak signal (0,1); 
moderate to strong signal (2,3)) whereas the same independent variables were used. Differences in signal 
strength (binary variable) between the binding sites endothelium-villi and endothelium-submucosa for 
unmodified explants were assessed via chi2 test. Kruskal-Wallis tests were performed to assess 
differences in TEER values between the different incubation groups for each point in time separately. 
Dunn’s Z multiple comparison tests were used to identify significant differences between different 
incubation groups. 
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Supplementary materials can be accessed at: http://www.mdpi.com/2072-6651/7/4/1235/s1. 
Acknowledgments 
Anti-CPB antibodies were kindly provided by G. Shrinivas (USDA, Ames, IA, USA), pro-aerolysin 
was kindly provided by G. van der Goot (Ecole Polytechnique de Lausanne). This study was supported by 
a Short International Visit Grant (HP) from the Swiss National Science Foundation (IZK0Z3_133953), 
a visiting foreign researcher grant from Ghent University (FVI, HP), a Swiss government scholarship 
(SR) and a grant from the Specialization Committee (Spezko) of the Vetsuisse Faculty. We thank Kerry 
Woods for English language corrections. 
Author Contributions 
S.R., M.W., A.C., N.R., H.P. conducted experiments; H.P. planned study; H.P. and F.V.I. planned 
explant experiments; C.N. performed statistical analyses. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Songer, J.G. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 1996, 9, 216–234. 
2. Petit, L.; Gibert, M.; Popoff, M.R. Clostridium perfringens: Toxinotype and genotype.  
Trends Microbiol. 1999, 7, 104–110. 
3. Amimoto, K.; Noro, T.; Oishi, E.; Shimizu, M. A novel toxin homologous to large clostridial cytotoxins 
found in culture supernatant of Clostridium perfringens type C. Microbiology 2007, 153, 1198–1206. 
4. Popoff, M.R.; Bouvet, P. Clostridial toxins. Future Microbiol. 2009, 4, 1021–1064. 
5. Jäggi, M.; Wollschlager, N.; Abril, C.; Albini, S.; Brachelente, C.; Wyder, M.; Posthaus, H. 
Retrospective study on necrotizing enteritis in piglets in switzerland. Schweiz. Arch. Tierheilkd. 
2009, 151, 369–375. 
Toxins 2015, 7 1251 
 
 
6. Sayeed, S.; Uzal, F.A.; Fisher, D.J.; Saputo, J.; Vidal, J.E.; Chen, Y.; Gupta, P.; Rood, J.I.; McClane, B.A. 
Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate 
cn3685 in a rabbit ileal loop model. Mol. Microbiol. 2008, 67, 15–30. 
7. Nagahama, M.; Hayashi, S.; Morimitsu, S.; Sakurai, J. Biological activities and pore formation of 
Clostridium perfringens beta toxin in hl 60 cells. J. Biol. Chem. 2003, 278, 36934–36941. 
8. Nagahama, M.; Shibutani, M.; Seike, S.; Yonezaki, M.; Takagishi, T.; Oda, M.; Kobayashi, K.; 
Sakurai, J. The p38 mapk and jnk pathways protect host cells against Clostridium perfringens  
beta-toxin. Inf. Immun. 2013, 81, 3703–3708. 
9. Uzal, F.A.; McClane, B.A. Recent progress in understanding the pathogenesis of Clostridium 
perfringens type C infections. Vet. Microbiol. 2011, 153, 37–43. 
10. Los, F.C.; Randis, T.M.; Aroian, R.V.; Ratner, A.J. Role of pore-forming toxins in bacterial 
infectious diseases. Microbiol .Mol. Biol. Rev. 2013, 77, 173–207. 
11. Gurtner, C.; Popescu, F.; Wyder, M.; Sutter, E.; Zeeh, F.; Frey, J.; von Schubert, C.; Posthaus, H. 
Rapid cytopathic effects of Clostridium perfringens beta-toxin on porcine endothelial cells.  
Inf. Immun. 2010, 78, 2966–2973. 
12. Popescu, F.; Wyder, M.; Gurtner, C.; Frey, J.; Cooke, R.A.; Greenhill, A.R.; Posthaus, H. 
Susceptibility of primary human endothelial cells to C. perfringens beta-toxin suggesting similar 
pathogenesis in human and porcine necrotizing enteritis. Vet. Microbiol. 2011, 153, 173–177. 
13. Autheman, D.; Wyder, M.; Popoff, M.; D’Herde, K.; Christen, S.; Posthaus, H.  
Clostridium perfringens beta-toxin induces necrostatin-inhibitable, calpain-dependent necrosis in 
primary porcine endothelial cells. PLoS One 2013, 8, e64644. 
14. Miclard, J.; Jaggi, M.; Sutter, E.; Wyder, M.; Grabscheid, B.; Posthaus, H. Clostridium perfringens  
β-toxin targets endothelial cells in necrotizing enteritis in piglets. Vet. Microbiol. 2009, 137, 320–325. 
15. Miclard, J.; van Baarlen, J.; Wyder, M.; Grabscheid, B.; Posthaus, H. Clostridium perfringens  
beta-toxin binding to vascular endothelial cells in a human case of enteritis necroticans. J. Med. 
Microbiol. 2009, 58, 826–828. 
16. Schumacher, V.L.; Martel, A.; Pasmans, F.; van Immerseel, F.; Posthaus, H. Endothelial binding of 
beta toxin to small intestinal mucosal endothelial cells in early stages of experimentally induced 
Clostridium perfringens type C enteritis in pigs. Vet. Pathol. 2013, 50, 626–629. 
17. Schierack, P.; Nordhoff, M.; Pollmann, M.; Weyrauch, K.D.; Amasheh, S.; Lodemann, U.; Jores, J.; 
Tachu, B.; Kleta, S.; Blikslager, A.; et al. Characterization of a porcine intestinal epithelial cell line 
for in vitro studies of microbial pathogenesis in swine. Histochem. Cell Biol. 2006, 125, 293–305. 
18. Abrami, L.; Fivaz, M.; Glauser, P.E.; Sugimoto, N.; Zurzolo, C.; van der Goot, F.G. Sensitivity of 
polarized epithelial cells to the pore-forming toxin aerolysin. Inf. Immun. 2003, 71, 739–746. 
19. Boyen, F.; Pasmans, F.; van Immerseel, F.; Donne, E.; Morgan, E.; Ducatelle, R.; Haesebrouck, F. 
Porcine in vitro and in vivo models to assess the virulence of salmonella enterica serovar 
typhimurium for pigs. Lab. Anim. 2009, 43, 46–52. 
20. Brosnahan, A.J.; Brown, D.R. Porcine ipec-j2 intestinal epithelial cells in microbiological investigations. 
Vet. Microbiol. 2012, 156, 229–237. 
21. Skrzypek, T.; Valverde Piedra, J.L.; Skrzypek, H.; Kazimierczak, W.; Biernat, M.; Zabielski, R. 
Gradual disappearance of vacuolated enterocytes in the small intestine of neonatal piglets.  
J. Physiol. Pharmacol. 2007, 58, 87–95. 
Toxins 2015, 7 1252 
 
 
22. Awad, M.M.; Ellemor, D.M.; Boyd, R.L.; Emmins, J.J.; Rood, J.I. Synergistic effects of alpha-toxin 
and Perfringolysin O in Clostridium perfringens-mediated gas gangrene. Inf. Immun. 2001, 69, 
7904–7910. 
23. Verherstraeten, S.; Goossens, E.; Valgaeren, B.; Pardon, B.; Timbermont, L.; Vermeulen, K.; 
Schauvliege, S.; Haesebrouck, F.; Ducatelle, R.; Deprez, P.; et al. The synergistic necrohemorrhagic 
action of Clostridium perfringens perfringolysin and alpha toxin in the bovine intestine and against 
bovine endothelial cells. Vet. Res. 2013, 44, 45. 
24. Ma, M.; Gurjar, A.; Theoret, J.R.; Garcia, J.P.; Beingesser, J.; Freedman, J.C.; Fisher, D.J.; 
McClane, B.A.; Uzal, F.A. Synergistic effects of Clostridium perfringens enterotoxin and beta toxin 
in rabbit small intestinal loops. Inf. Immun. 2014, 82, 2958–2970. 
25. Vidal, J.E.; McClane, B.A.; Saputo, J.; Parker, J.; Uzal, F.A. Effects of Clostridium perfringens 
beta-toxin on the rabbit small intestine and colon. Inf. Immun. 2008, 76, 4396–4404. 
26. Uzal, F.A.; Saputo, J.; Sayeed, S.; Vidal, J.E.; Fisher, D.J.; Poon, R.; Adams, V.;  
Fernandez-Miyakawa, M.E.; Rood, J.I.; McClane, B.A. Development and application of new mouse 
models to study the pathogenesis of Clostridium perfringens type C enterotoxemias. Inf. Immun. 
2009, 77, 5291–5299. 
27. Popoff, M.R. Clostridial pore-forming toxins: Powerful virulence factors. Anaerobe 2014, 30, 220–238. 
28. Steinthorsdottir, V.; Halldorsson, H.; Andresson, O.S. Clostridium perfringens beta-toxin forms 
multimeric transmembrane pores in human endothelial cells. Microb. Pathog. 2000, 28, 45–50. 
29. Manich, M.; Knapp, O.; Gibert, M.; Maier, E.; Jolivet-Reynaud, C.; Geny, B.; Benz, R.; Popoff, M.R. 
Clostridium perfringens delta toxin is sequence related to beta toxin, netb, and staphylococcus  
pore-forming toxins, but shows functional differences. PLoS One 2008, 3, e3764. 
30. Shatursky, O.; Bayles, R.; Rogers, M.; Jost, B.H.; Songer, J.G.; Tweten, R.K. Clostridium perfringens 
beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Inf. Immun. 2000, 
68, 5546–5551. 
31. Vidal, J.E.; Ohtani, K.; Shimizu, T.; McClane, B.A. Contact with enterocyte-like caco-2 cells 
induces rapid upregulation of toxin production by Clostridium perfringens type C isolates.  
Cell. Microbiol. 2009, 11, 1306–1328. 
32. Fisher, D.J.; Fernandez-Miyakawa, M.E.; Sayeed, S.; Poon, R.; Adams, V.; Rood, J.I.; Uzal, F.A.; 
McClane, B.A. Dissecting the contributions of Clostridium perfringens type C toxins to lethality in 
the mouse intravenous injection model. Inf. Immun. 2006, 74, 5200–5210. 
33. Stevens, D.L.; Mitten, J.; Henry, C. Effects of alpha and theta toxins from Clostridium perfringens 
on human polymorphonuclear leukocytes. J. Inf. Dis. 1987, 156, 324–333. 
34. Krause, K.H.; Fivaz, M.; Monod, A.; van der Goot, F.G. Aerolysin induces g-protein activation and 
Ca2+ release from intracellular stores in human granulocytes. J. Biol. Chem. 1998, 273, 18122–18129. 
35. Fromter, E.; Diamond, J. Route of passive ion permeation in epithelia. Nat. New Biol. 1972, 235, 9–13. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
